Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Panelists discuss how deep learning applied to imaging data sets may advance kidney cancer assessment, though they believe the next major leap will require true molecular imaging that reveals what tumors are expressing.
Adjuvant pembrolizumab showed maintained OS and DFS vs placebo in patients with ccRCC at the 5-year analysis.
During a live event, Chandler H. Park, MD, and event participants looked at quality of life, tolerability, and rechallenging in second-line RCC therapy.
During a live event, Chandler H. Park, MD, and event participants looked at quality of life, tolerability, and rechallenging in second-line RCC therapy.
Experts hope their findings will help improve diagnosis times.
A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation portion of the clinical trial.
Kidney renal clear cell carcinoma (KIRC), a cancer characterized by substantial immune infiltration, exhibits limited sensitivity to conventional radiochemotherapy. Although immunotherapy has shown efficacy in some patients, its applicability is not universally effective. Studies have ...
Imaging advancements in ccRCC are crucial for predicting tumor biology and enhancing treatment strategies through molecular imaging techniques.
Explore the role of biopsies in managing ccRCC, especially in elderly patients, to optimize treatment decisions and preserve kidney function.
Fructose-1, 6-bisphosphatase (FBP1) is a tumor suppressor and frequently deficient in various cancers, including clear cell renal cell carcinoma (ccRCC). VHL inactivation mutations are usually observed in ccRCC, which can lead to abnormal activation of the HIF signaling pathway. FBP1 could ...
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.